Carrier-mediated delivery holds
great promise for si
gnificantly improvin
g the cellular uptake andtherefore the therapeutic efficacy of antisense oli
gonucleotides in vivo. A multivalent carbohydratereco
gnition motif for the asialo
glycoprotein receptor has been desi
gned for tissue- and cell-specificdelivery of antisense dru
gs to parenchymal liver cells. To combine low molecular wei
ght with hi
ghreceptor affinity, the synthetic li
gand contains three
galactosyl residues attached to a cholane scaffoldvia
ges/
gifchars/epsilon.
gif" BORDER=0 >-aminocapramide linkers. Three-dimensional structural calculations indicate that this uniquedesi
gn provides proper spacin
g and orientation of the three
galactosyl residues to accomplish hi
ghaffinity bindin
g to the receptor. Covalent conju
gation of the bulky carbohydrate cluster to oli
gonucleotides has been achieved by solid-phase synthesis usin
g low-loaded macroporous resins and optimizedsynthesis protocols.